Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)

Long-term ADT combined with definitive pelvic external beam RT for cT1-4N1M0 PCa leaded to favorable outcomes. Future prospective studies should validate the suggested survival benefit of local dose escalation to the prostate in this cohort.

Authors

Institutions

Publication Details

Journal
Journal of Radiation Research
Published
2025-03-01
DOI
https://doi.org/10.1093/jrr/rraf005
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)

Kiyonao Nakamura, Keiichi Jingu, Hiromitsu Iwata, Takeshi Akiba et al.
Journal of Radiation Research
Prostate Cancer Diagnosis and Treatment
article

Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)

Kiyonao Nakamura, Keiichi Jingu, Hiromitsu Iwata, Takeshi Akiba, Toshiya Maebayashi, Takashi Mizowaki, Natsuo Tomita, Hiroyuki Wada, Katsumasa Nakamura, Hitoshi Ishikawa, Koji Inaba, Masakuni Sakaguchi, Satoshi Itasaka, Hirofumi Asakura
article en

Abstract

Long-term ADT combined with definitive pelvic external beam RT for cT1-4N1M0 PCa leaded to favorable outcomes. Future prospective studies should validate the suggested survival benefit of local dose escalation to the prostate in this cohort.

Journal of Radiation ResearchVol. 66(2)
Nihon University (JP), Jikei University School of Medicine (JP), Tokai University (JP), Tohoku University (JP), Kyoto University (JP), Hamamatsu University School of Medicine (JP), Nagoya City University (JP), Shizuoka Cancer Center (JP), National Cancer Center (US), Kurashiki Central Hospital (JP), National Institutes for Quantum Science and Technology (JP), Mizuho (Japan) (JP)
Openalex Percentile: Top 94%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG) — Kiyonao Nakamura, Keiichi Jingu, et al. · Journal of Radiation Research (2025) | TGRS Research Map | TGRS